What is Spero Therapeutics, Inc. Common Stock's Market Cap?

Spero Therapeutics, Inc. Common Stock's Market Cap is $69.3M, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Enterprise Value?

Spero Therapeutics, Inc. Common Stock's Enterprise Value is $18.5M, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Trailing P/E?

Spero Therapeutics, Inc. Common Stock's Trailing P/E is 9.4×, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Price / Sales?

Spero Therapeutics, Inc. Common Stock's Price / Sales is 1.5×, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's EV / Revenue?

Spero Therapeutics, Inc. Common Stock's EV / Revenue is 0.4×, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's EV / EBITDA?

Spero Therapeutics, Inc. Common Stock's EV / EBITDA is 3.3×, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Revenue (TTM)?

Spero Therapeutics, Inc. Common Stock's Revenue (TTM) is $47.0M, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Net Income (TTM)?

Spero Therapeutics, Inc. Common Stock's Net Income (TTM) is $7.4M, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's EBITDA?

Spero Therapeutics, Inc. Common Stock's EBITDA is $6.0M, based on as-reported figures from SEC (XBRL) filings.

What is Spero Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Spero Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.13, based on as-reported figures from SEC (XBRL) filings.

Spero Therapeutics, Inc. Common Stock (SPRO) Financial Statements

Spero Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG00HXSJ1S1

XNAS · usd

1.19▼ 0.02 (-1.65%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close1.21

Day's Range1.19 – 1.22

52-Week Range1.08 – 3.08

Volume347.5K

Avg Volume578.0K

Share Statistics

Shares Outstanding

Employees25

ExchangeXNAS

Listed2017-11-02

Share count as of August 7, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Spero Therapeutics, Inc. Common Stock (SPRO)

What is Spero Therapeutics, Inc. Common Stock's Market Cap?: Spero Therapeutics, Inc. Common Stock's Market Cap is $69.3M, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Enterprise Value?: Spero Therapeutics, Inc. Common Stock's Enterprise Value is $18.5M, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Trailing P/E?: Spero Therapeutics, Inc. Common Stock's Trailing P/E is 9.4×, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Price / Sales?: Spero Therapeutics, Inc. Common Stock's Price / Sales is 1.5×, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's EV / Revenue?: Spero Therapeutics, Inc. Common Stock's EV / Revenue is 0.4×, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's EV / EBITDA?: Spero Therapeutics, Inc. Common Stock's EV / EBITDA is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Revenue (TTM)?: Spero Therapeutics, Inc. Common Stock's Revenue (TTM) is $47.0M, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Net Income (TTM)?: Spero Therapeutics, Inc. Common Stock's Net Income (TTM) is $7.4M, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's EBITDA?: Spero Therapeutics, Inc. Common Stock's EBITDA is $6.0M, based on as-reported figures from SEC (XBRL) filings.
What is Spero Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Spero Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is 0.13, based on as-reported figures from SEC (XBRL) filings.